Somatic Symptom Disorder
Conditions
Interventions
Cognitive Behavioral Group Therapy
Treatment as usual
Sponsors
Kyoto Prefectural University of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The subjects will be those who have been diagnosed with somatic and related symptoms using DSM5, who have given a written explanation of the purpose of the study and the benefits and disadvantages of participating in the study, and who have given their consent to the study. The subjects of this study must be at or above 18 years of age.
Exclusion criteria
Exclusion criteria: (1)Those who have insufficient ability to speak and understand Japanese. (2)Persons undergoing other professional psychotherapy or clinical trials (3)Other patients who are deemed inappropriate by the doctor in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PHQ 15 (Patient Health Questionnaire 15), SSD 12 (The Somatic Symptom Disorder, B Criteria Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| PHQ-9 (Patient Health Questionnaire-9), GAD-7 (Generalized Anxiety Disorder-7), VAS (Visual analog Scale), PCS (Pain Catastrophe Scale), EQ-5D-5L, SHAI (Short Health Anxiety Inventory), SIUS (The Short Intolerance of Uncertainty Scale) and others | — |
Countries
Japan
Contacts
Public ContactToshiyuki Tominaga
Kyoto Prefectural University of Medicine Department of Psychiatry, Graduate School of Medical Science
Outcome results
None listed